Venture Capital

For the third year, Brightline is a top startup employer. We explore how its unique model of growth and compassion is changing pediatric mental healthcare.

Palo Alto Networks founder argues AI won't kill cybersecurity, citing data costs and compliance as major roadblocks for today's AI security solutions.

Zelestra begins construction on two huge solar farms in Texas, backed by Meta, promising hundreds of jobs and a major boost to the state's green grid.

With a severe doctor shortage, one company just raised millions to prove nurse practitioners are the future of primary care for America's seniors.

Top exec search firm Christian & Timbers moves from placing leaders to deploying AI, launching a new arm to deliver measurable ROI with Agentic systems.

A new partnership is pioneering a data-driven family engagement platform, setting a new standard for pediatric health and digital transformation.

At MWC26, iFLYTEK launched ambitious AI translation glasses, but faces stiff competition from Google and Alibaba, along with lingering privacy questions.

BioRestorative Therapies is leveraging its clinical-grade regenerative medicine to disrupt the aesthetics industry. Can science beat marketing?

Asia's top tech expo unveils its 2026 theme, focusing on AI's leap from code to robotics, wearables, and smart systems, cementing the region's global role.

AI firm YXT.com lands on a top innovation list with tech giants, but can its cutting-edge training solutions navigate a complex market and redefine work?

Taiwanese biotech GNTbm's oral drug GNTbm-38, which turns 'cold' tumors 'hot', will begin Phase 1 trials for advanced and refractory cancers.

Starton Therapeutics files patents to combine its continuous low-dose therapy, STAR-LLD, with CAR-T, aiming to enhance cancer-killing power and durability.

With a total of $160M in Series B funding, Atavistik Bio is advancing its selective allosteric inhibitors for rare diseases HHT and MPNs.

Beating Wall Street estimates with historic gross profits, the chipmaker leverages new capital and key partnerships to push its ultra-low-power tech deeper into AI.

With a new outpatient model, NexCure aims to bring life-saving cancer treatments like CAR-T closer to home, tackling a major healthcare bottleneck.

With mixed trial results for its obesity drug and rising costs, Skye Bioscience's upcoming 2025 earnings call is a pivotal moment for investors.

A landmark partnership between Pivot Energy and Microsoft invests in communities, starting with $400,000 in Maryland, tying solar power to local jobs and resilience.

Following key acquisitions, the AI firm pivots to a vertically integrated defense powerhouse, forecasting explosive growth backed by a swelling order backlog.

The deal merges Bonterra’s enterprise grantmaking with Deed’s modern employee engagement platform, signaling a major shift in corporate social responsibility.

With a new CEO known for scaling firms for acquisition, AI-native platform CYPHER Learning signals a major push for dominance in enterprise training.